Total Payments
$9,213
2024 Payments
$1,332
Companies
59
Transactions
567
Medicare Patients
3,442
Medicare Billing
$400,382
Payment Breakdown by Category
Food & Beverage$9,049 (98.2%)
Education$164.31 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,049 | 559 | 98.2% |
| Education | $164.31 | 8 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,290 | 90 | $0 (2024) |
| Allergan, Inc. | $1,101 | 68 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,039 | 59 | $0 (2024) |
| Novo Nordisk Inc | $697.45 | 46 | $0 (2024) |
| Lilly USA, LLC | $602.38 | 47 | $0 (2024) |
| Amgen Inc. | $568.64 | 29 | $0 (2024) |
| PFIZER INC. | $358.46 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $323.81 | 18 | $0 (2023) |
| Merck Sharp & Dohme LLC | $280.77 | 19 | $0 (2024) |
| Antares Pharma, Inc. | $261.69 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,332 | 71 | ABBVIE INC. ($304.72) |
| 2023 | $921.17 | 51 | AbbVie Inc. ($218.75) |
| 2022 | $648.23 | 44 | ABBVIE INC. ($181.96) |
| 2021 | $1,193 | 86 | Novo Nordisk Inc ($248.32) |
| 2020 | $971.47 | 70 | Allergan, Inc. ($193.06) |
| 2019 | $1,191 | 79 | Allergan Inc. ($317.56) |
| 2018 | $1,496 | 86 | Allergan Inc. ($405.32) |
| 2017 | $1,459 | 80 | Shire North American Group Inc ($189.28) |
All Payment Transactions
567 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: VACCINE | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Bone Health | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/08/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Cardio-renal | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,237 | 1,908 | $246,873 | $155,896 |
| 2022 | 23 | 934 | 1,440 | $167,259 | $108,068 |
| 2021 | 15 | 714 | 1,071 | $130,543 | $84,942 |
| 2020 | 11 | 557 | 838 | $97,406 | $51,476 |
Total Patients
3,442
Total Services
5,257
Medicare Billing
$400,382
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 812 | $125,860 | $73,698 | 58.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 132 | 132 | $22,440 | $17,154 | 76.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 120 | $22,800 | $14,669 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 152 | $15,960 | $9,409 | 59.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $9,325 | $8,177 | 87.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 45 | 45 | $7,875 | $5,653 | 71.8% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 33 | 39 | $6,513 | $5,451 | 83.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 65 | 65 | $6,348 | $4,593 | 72.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $10,175 | $4,451 | 43.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,330 | $2,141 | 91.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $2,490 | $1,920 | 77.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 45 | 45 | $2,250 | $1,821 | 80.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 11 | 11 | $2,200 | $1,639 | 74.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 72 | 72 | $1,800 | $1,356 | 75.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $1,200 | $980.16 | 81.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 51 | $2,040 | $891.12 | 43.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,015 | $555.12 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 43 | $1,505 | $469.55 | 31.2% |
| 90471 | Administration of vaccine | Office | 2023 | 15 | 17 | $595.00 | $263.36 | 44.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 14 | $308.00 | $226.80 | 73.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 43 | 60 | $360.00 | $204.60 | 56.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 14 | $294.00 | $133.28 | 45.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 19 | 19 | $190.00 | $37.91 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 433 | $67,130 | $39,201 | 58.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 89 | 119 | $22,610 | $15,414 | 68.2% |
About Dr. Christopher West, D.O
Dr. Christopher West, D.O is a Family Medicine healthcare provider based in Parker, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265491112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher West, D.O has received a total of $9,213 in payments from pharmaceutical and medical device companies, with $1,332 received in 2024. These payments were reported across 567 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($9,049).
As a Medicare-enrolled provider, West has provided services to 3,442 Medicare beneficiaries, totaling 5,257 services with total Medicare billing of $400,382. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Parker, CO
- Active Since 03/20/2006
- Last Updated 03/10/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265491112
Products in Payments
- VRAYLAR (Drug) $1,149
- FARXIGA (Drug) $519.19
- UBRELVY (Drug) $376.63
- Ozempic (Drug) $253.51
- XYOSTED (Drug) $232.96
- TRULICITY (Drug) $211.72
- SHINGRIX (Biological) $196.53
- MOUNJARO (Drug) $196.48
- Aimovig (Biological) $186.06
- Synthroid (Drug) $184.82
- MYDAYIS (Drug) $184.39
- ZONTIVITY (Drug) $173.53
- QULIPTA (Drug) $169.07
- JARDIANCE (Drug) $150.71
- VIIBRYD (Drug) $145.58
- Repatha (Biological) $137.91
- NURTEC ODT (Drug) $132.87
- AIRSUPRA (Drug) $128.82
- Dayvigo (Drug) $123.10
- SYMBICORT (Drug) $117.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Parker
Dr. Patricia Fahey, M.d, M.D
Family Medicine — Payments: $4,588
Family Medicine $4,588
Dr. Christen Vu, D.o, D.O
Family Medicine — Payments: $4,570
Family Medicine $4,570
Dr. Michael Elder, D.o, D.O
Family Medicine — Payments: $4,407
Family Medicine $4,407
Dr. Barton Butterbaugh, M.d, M.D
Family Medicine — Payments: $3,830
Family Medicine $3,830
Ian Bach, Md, MD
Family Medicine — Payments: $3,490
Family Medicine $3,490
Mary Nguyen, M.d, M.D
Family Medicine — Payments: $2,169
Family Medicine $2,169